TendieTensor TendieTensor
You’re browsing as
Guest
Free Preview
Sign in/sign up to unlock all features.

News  ›  GlobeNewswire Inc.

Belite Bio Announces Pricing of $350.0 Million Underwritten Public Offering of American Depositary Shares

GlobeNewswire Inc. Logo GlobeNewswire Inc. By Jennifer Wu / Julie Fallon
Belite Bio Announces Pricing of $350.0 Million Underwritten Public Offering of American Depositary Shares

Belite Bio has priced a public offering of 2,272,727 American Depositary Shares at $154.00 per share, expecting to raise approximately $350 million to fund commercialization preparation, pipeline development, and general corporate purposes.

Insights
FGSN   neutral

Company is being partially distributed to shareholders without significant positive or negative implications


BLTE   neutral

The company is raising capital through a standard public offering to support its ongoing clinical development and commercialization efforts, indicating a strategic financial move without strong positive or negative implications